$JXN
Jackson Financial Inc.

2023 Q3 Form 10-Q Financial Statement

#000182299323000035 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $6.694B $2.221B
YoY Change 66.43% -65.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.045B $1.042B
YoY Change 8.74% 15.27%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $307.0M $317.0M
YoY Change 15250.0% 10466.67%
% of Gross Profit
Operating Expenses -$945.0M -$1.113B
YoY Change -148.07% -139.14%
Operating Profit
YoY Change
Interest Expense $49.00M $58.00M
YoY Change 68.97% 141.67%
% of Operating Profit
Other Income/Expense, Net -$24.00M
YoY Change -138.71%
Pretax Income $4.139B $2.613B
YoY Change 104.19% -28.43%
Income Tax $845.0M $388.0M
% Of Pretax Income 20.42% 14.85%
Net Earnings $3.263B $2.194B
YoY Change 120.62% -24.42%
Net Earnings / Revenue 48.75% 98.78%
Basic Earnings Per Share $37.96 $25.41
Diluted Earnings Per Share $36.59 $24.39
COMMON SHARES
Basic Shares Outstanding 81.91M shares 82.49M shares
Diluted Shares Outstanding 82.82M shares 84.75M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.760B $2.100B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $60.20B $63.34B
YoY Change -5.85% -3.87%
Other Assets $632.0M $681.0M
YoY Change -16.73% -30.58%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $314.5B $327.0B
YoY Change 3.82% 3.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.172B $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $450.0M $498.0M
YoY Change -56.65% -19.81%
LONG-TERM LIABILITIES
Long-Term Debt $2.635B $2.633B
YoY Change 0.04% -0.04%
Other Long-Term Liabilities $7.191B $5.916B
YoY Change 13.75% 11.85%
Total Long-Term Liabilities $9.826B $8.549B
YoY Change 9.71% 7.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $450.0M $498.0M
Total Long-Term Liabilities $9.826B $8.549B
Total Liabilities $304.3B $317.6B
YoY Change 3.76% 3.81%
SHAREHOLDERS EQUITY
Retained Earnings $8.661B $5.952B
YoY Change -4.46% -22.04%
Common Stock $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.478B $8.652B
YoY Change
Total Liabilities & Shareholders Equity $314.5B $327.0B
YoY Change 3.82% 3.41%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $3.263B $2.194B
YoY Change 120.62% -24.42%
Depreciation, Depletion And Amortization $307.0M $317.0M
YoY Change 15250.0% 10466.67%
Cash From Operating Activities $1.129B $1.086B
YoY Change 33.61% -12.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.119B $78.00M
YoY Change -1551.37% -97.23%
Cash From Investing Activities $2.119B $78.00M
YoY Change -1551.37% -97.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.586B -842.0M
YoY Change 314.42% -42.6%
NET CHANGE
Cash From Operating Activities 1.129B 1.086B
Cash From Investing Activities 2.119B 78.00M
Cash From Financing Activities -2.586B -842.0M
Net Change In Cash 662.0M 322.0M
YoY Change 782.67% -87.55%
FREE CASH FLOW
Cash From Operating Activities $1.129B $1.086B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82690098 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82690098 shares
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1497000000 usd
jxn Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties
NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties
2105000000 usd
us-gaap Market Risk Benefit Change In Fair Value Gain Loss
MarketRiskBenefitChangeInFairValueGainLoss
723000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10453000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9378000000 usd
us-gaap Profit Loss
ProfitLoss
-276000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 usd
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
35000000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
13000000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
107000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
164000000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
533000000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
533000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9423000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8321000000 usd
us-gaap Profit Loss
ProfitLoss
5519000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3099000000 usd
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
5000000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
102000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
240000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10453000000 usd
us-gaap Profit Loss
ProfitLoss
5519000000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-125000000 usd
us-gaap Liability For Future Policy Benefit Remeasurement Gain Loss
LiabilityForFuturePolicyBenefitRemeasurementGainLoss
-29000000 usd
us-gaap Interest Credited To Policy Owner Account
InterestCreditedToPolicyOwnerAccount
406000000 usd
jxn Mortality Expense And Surrender Charges
MortalityExpenseAndSurrenderCharges
269000000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-13000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1261000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
69000000 usd
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
2000000 usd
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-275000000 usd
us-gaap Increase Decrease In Funds Held Under Reinsurance Agreements
IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements
-224000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1273000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2052000000 usd
jxn Proceeds From Sale And Maturity Of Debt Securities
ProceedsFromSaleAndMaturityOfDebtSecurities
6942000000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
43000000 usd
us-gaap Proceeds From Sale And Collection Of Finance Receivables
ProceedsFromSaleAndCollectionOfFinanceReceivables
551000000 usd
jxn Payments To Acquire Debt Securities
PaymentsToAcquireDebtSecurities
5981000000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
25000000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
1039000000 usd
jxn Payments For Proceeds From Derivative Instruments And Collateral On Investments
PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments
-2570000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
446000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2615000000 usd
us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
10282000000 usd
us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
12936000000 usd
jxn Transfers To From Separate Accounts
TransfersToFromSeparateAccounts
2554000000 usd
us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-1557000000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-46000000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
101000000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
13000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
164000000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
533000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1941000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2198000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4301000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
99000000 usd
jxn Debt Securities Acquired From Noncash Transactions
DebtSecuritiesAcquiredFromNoncashTransactions
49000000 usd
jxn Other Invested Assets Acquired From Stock Splits And Stock Distributions
OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions
181000000 usd
jxn Non Cash Dividend Equivalents On Stock Based Awards
NonCashDividendEquivalentsOnStockBasedAwards
6000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2100000000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
3000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in the notes, include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessments as to whether certain entities are VIEs, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating policy reserves and liabilities including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating market risk benefits including policyholder behavior, mortality rates, and capital market assumptions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions impacting the expected term used amortizing deferred acquisition costs, including policyholder behavior and mortality rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the consolidated financial statements in the periods the estimates are changed.</span></div>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
In 2022, the Company identified errors related to the classification of certain balances and amounts in the line items of the Condensed Consolidated Balance Sheets and Condensed Consolidated Income Statements. These errors resulted in the revision of balances and amounts related to deferred sales inducement assets, liabilities for certain life-contingent annuities, sub-advisor fee expenses, and other operating expense items that impacted previously issued Condensed Consolidated Financial Statements. The impact of these errors to the prior periods' Condensed Consolidated Financial Statements were not considered to be material and had no impact on shareholders' equity or net income (loss). However, to improve the consistency and comparability of the financial statements, management revised the financial statements and related disclosures in this quarterly report. See Note 22 to the Notes to Condensed Consolidated Financial Statements for details of the revisions.
CY2023Q2 jxn Debt Securities Percentage
DebtSecuritiesPercentage
1.000
CY2022Q4 jxn Debt Securities Percentage
DebtSecuritiesPercentage
1.000
CY2023Q2 jxn Debt Securities Amortized Cost
DebtSecuritiesAmortizedCost
50182000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss
DebtSecuritiesAllowanceForCreditLoss
16000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
119000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5911000000 usd
CY2023Q2 us-gaap Debt Securities
DebtSecurities
44374000000 usd
CY2022Q4 jxn Debt Securities Amortized Cost
DebtSecuritiesAmortizedCost
51071000000 usd
CY2022Q4 jxn Debt Securities Allowance For Credit Loss
DebtSecuritiesAllowanceForCreditLoss
23000000 usd
CY2022Q4 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
115000000 usd
CY2022Q4 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6401000000 usd
CY2022Q4 us-gaap Debt Securities
DebtSecurities
44762000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne
1971000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne
1000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne
0 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne
11000000 usd
CY2023Q2 jxn Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne
1959000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five
DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
10622000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five
DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
2000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive
5000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive
482000000 usd
CY2023Q2 jxn Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five
DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
10143000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten
DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen
13542000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten
DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen
4000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen
35000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen
1409000000 usd
CY2023Q2 jxn Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten
DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen
12164000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty
DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty
9076000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty
DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty
3000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty
49000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty
1517000000 usd
CY2023Q2 jxn Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty
DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty
7605000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty
DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty
7501000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty
DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty
0 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty
6000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty
1819000000 usd
CY2023Q2 jxn Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty
DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty
5688000000 usd
CY2023Q2 jxn Debt Securities Amortized Cost
DebtSecuritiesAmortizedCost
50182000000 usd
CY2023Q2 jxn Debt Securities Allowance For Credit Loss
DebtSecuritiesAllowanceForCreditLoss
16000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
119000000 usd
CY2023Q2 jxn Debt Securities Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5911000000 usd
CY2023Q2 us-gaap Debt Securities
DebtSecurities
44374000000 usd
CY2023Q2 us-gaap Securities Reserve Deposit Required And Made
SecuritiesReserveDepositRequiredAndMade
93000000 usd
CY2022Q4 us-gaap Securities Reserve Deposit Required And Made
SecuritiesReserveDepositRequiredAndMade
90000000 usd
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
521000000 usd
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months
11713000000 usd
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
1342 security
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5390000000 usd
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger
27487000000 usd
CY2023Q2 jxn Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
3431 security
CY2023Q2 jxn Debt Securities Unrealized Loss Position Accumulated Loss
DebtSecuritiesUnrealizedLossPositionAccumulatedLoss
5911000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
18000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
63000000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
43000000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
241000000 usd
us-gaap Net Investment Income
NetInvestmentIncome
1382000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
2000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
5000000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
6000000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
29000000 usd
CY2023Q2 jxn Debt Securities Unrealized Loss Position
DebtSecuritiesUnrealizedLossPosition
39200000000 usd
CY2023Q2 jxn Debt Securities Unrealized Loss Position Number Of Positions
DebtSecuritiesUnrealizedLossPositionNumberOfPositions
4535 security
jxn Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag
Accrued interest receivable
jxn Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag
Accrued interest receivable
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded
1000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal
1000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date
DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold
15000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
16000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded
6000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal
6000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date
DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff
1000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
43000000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
23000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded
33000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal
2000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date
DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate
0 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff
0 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold
25000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery
17000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
16000000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
9000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded
39000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal
1000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date
DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate
0 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff
0 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold
1000000 usd
us-gaap Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery
DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery
5000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
43000000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
429000000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
382000000 usd
CY2023Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
5000000 usd
CY2022Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
36000000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
120000000 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
79000000 usd
CY2023Q2 jxn Net Investment Income Excluding Funds Withheld Assets
NetInvestmentIncomeExcludingFundsWithheldAssets
420000000 usd
CY2022Q2 jxn Net Investment Income Excluding Funds Withheld Assets
NetInvestmentIncomeExcludingFundsWithheldAssets
328000000 usd
jxn Net Investment Income Excluding Funds Withheld Assets
NetInvestmentIncomeExcludingFundsWithheldAssets
835000000 usd
jxn Net Investment Income Excluding Funds Withheld Assets
NetInvestmentIncomeExcludingFundsWithheldAssets
758000000 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
672000000 usd
CY2022Q2 us-gaap Net Investment Income
NetInvestmentIncome
692000000 usd
us-gaap Net Investment Income
NetInvestmentIncome
1394000000 usd
CY2023Q2 jxn Debt Securities Available For Sale Credit Loss Expense Reversal
DebtSecuritiesAvailableForSaleCreditLossExpenseReversal
0 usd
CY2022Q2 jxn Debt Securities Available For Sale Credit Loss Expense Reversal
DebtSecuritiesAvailableForSaleCreditLossExpenseReversal
-1000000 usd
jxn Debt Securities Available For Sale Credit Loss Expense Reversal
DebtSecuritiesAvailableForSaleCreditLossExpenseReversal
11000000 usd
jxn Debt Securities Available For Sale Credit Loss Expense Reversal
DebtSecuritiesAvailableForSaleCreditLossExpenseReversal
-1000000 usd
CY2023Q2 jxn Financing Receivable Credit Loss Expense Reversal And Other Gain Loss
FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss
13000000 usd
CY2022Q2 jxn Financing Receivable Credit Loss Expense Reversal And Other Gain Loss
FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss
9000000 usd
jxn Financing Receivable Credit Loss Expense Reversal And Other Gain Loss
FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss
60000000 usd
jxn Financing Receivable Credit Loss Expense Reversal And Other Gain Loss
FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss
-3000000 usd
CY2023Q2 jxn Other Operating Gain Loss
OtherOperatingGainLoss
-11000000 usd
CY2022Q2 jxn Other Operating Gain Loss
OtherOperatingGainLoss
71000000 usd
jxn Other Operating Gain Loss
OtherOperatingGainLoss
0 usd
jxn Other Operating Gain Loss
OtherOperatingGainLoss
83000000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-40000000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
5000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-108000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-125000000 usd
CY2023Q2 jxn Gain Loss On Investments And Derivative Instruments
GainLossOnInvestmentsAndDerivativeInstruments
-2112000000 usd
CY2022Q2 jxn Gain Loss On Investments And Derivative Instruments
GainLossOnInvestmentsAndDerivativeInstruments
2938000000 usd
jxn Gain Loss On Investments And Derivative Instruments
GainLossOnInvestmentsAndDerivativeInstruments
-4838000000 usd
jxn Gain Loss On Investments And Derivative Instruments
GainLossOnInvestmentsAndDerivativeInstruments
1372000000 usd
CY2023Q2 jxn Gain Loss On Investments And Derivative Instruments Net
GainLossOnInvestmentsAndDerivativeInstrumentsNet
-2246000000 usd
CY2022Q2 jxn Gain Loss On Investments And Derivative Instruments Net
GainLossOnInvestmentsAndDerivativeInstrumentsNet
4015000000 usd
jxn Gain Loss On Investments And Derivative Instruments Net
GainLossOnInvestmentsAndDerivativeInstrumentsNet
-5645000000 usd
jxn Gain Loss On Investments And Derivative Instruments Net
GainLossOnInvestmentsAndDerivativeInstrumentsNet
3477000000 usd
CY2023Q2 jxn Aggregate Fair Value Of Securities Sold At A Loss
AggregateFairValueOfSecuritiesSoldAtALoss
356000000 usd
jxn Aggregate Fair Value Of Securities Sold At A Loss
AggregateFairValueOfSecuritiesSoldAtALoss
2153000000 usd
CY2023Q2 jxn Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value
AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue
0.93
jxn Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value
AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue
0.96
CY2022Q2 jxn Aggregate Fair Value Of Securities Sold At A Loss
AggregateFairValueOfSecuritiesSoldAtALoss
506000000 usd
jxn Aggregate Fair Value Of Securities Sold At A Loss
AggregateFairValueOfSecuritiesSoldAtALoss
2898000000 usd
CY2022Q2 jxn Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value
AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue
0.93
jxn Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value
AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue
0.92
CY2023Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1300000000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3300000000 usd
CY2022Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
800000000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4900000000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
276000000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-50000000 usd
CY2023Q2 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
3016000000 usd
CY2022Q4 us-gaap Variable Interest Entity Entity Maximum Loss Exposure Amount
VariableInterestEntityEntityMaximumLossExposureAmount
3285000000 usd
jxn Interest And Principal Payment Deferral Repayment Period Covid19
InterestAndPrincipalPaymentDeferralRepaymentPeriodCOVID19
P1Y
CY2023Q2 jxn Deferred Interest And Principal Payment Amount Covid19
DeferredInterestAndPrincipalPaymentAmountCOVID19
9000000 usd
CY2023Q2 jxn Financing Receivable Stressed Loans
FinancingReceivableStressedLoans
3000000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
146000000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
16000000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
162000000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
84000000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
CY2022Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-4000000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
80000000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
95000000 usd
us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
67000000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
162000000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
94000000 usd
us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
0 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-14000000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
80000000 usd
CY2023Q2 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
44000000 usd
CY2022Q2 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
44000000 usd
CY2023Q2 jxn Financing Receivable90 Days Or More Past Due Still Accruing Writeoff
FinancingReceivable90DaysOrMorePastDueStillAccruingWriteoff
2000000 usd
CY2022Q2 jxn Financing Receivable90 Days Or More Past Due Still Accruing Writeoff
FinancingReceivable90DaysOrMorePastDueStillAccruingWriteoff
0 usd
CY2023Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
13000000 usd
CY2023Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
14000000 usd
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
15000000 usd
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 usd
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
15000000 usd
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16000000 usd
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18000000 usd
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
510000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
1202000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
1630000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
871000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
1442000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
5153000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Revolving
FinancingReceivableExcludingAccruedInterestRevolving
4000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
10812000000 usd
CY2023Q2 srt Financing Receivable Before Allowance For Credit Loss To Total Percent
FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent
1
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
1315000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
1927000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
1260000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
1554000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
1511000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
3978000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Revolving
FinancingReceivableExcludingAccruedInterestRevolving
4000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
11549000000 usd
CY2022Q4 srt Financing Receivable Before Allowance For Credit Loss To Total Percent
FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent
1
CY2023Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0 usd
CY2023Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
13000000 usd
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
10812000000 usd
CY2022Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0 usd
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
15000000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
11549000000 usd
CY2022Q4 jxn Financing Receivable Stressed Loans
FinancingReceivableStressedLoans
3000000 usd
CY2023Q2 jxn Loans Gross Insurance Policy Fair Value Option
LoansGrossInsurancePolicyFairValueOption
3400000000 usd
CY2022Q4 jxn Loans Gross Insurance Policy Fair Value Option
LoansGrossInsurancePolicyFairValueOption
3400000000 usd
CY2022Q4 jxn Loans Gross Insurance Policy Not Held As Collateral
LoansGrossInsurancePolicyNotHeldAsCollateral
1000000000.0 usd
CY2022Q4 jxn Loans Gross Insurance Policy Not Held As Collateral
LoansGrossInsurancePolicyNotHeldAsCollateral
1000000000.0 usd
CY2023Q2 jxn Securities Loaned Fair Value Disclosure
SecuritiesLoanedFairValueDisclosure
51000000 usd
CY2022Q4 jxn Securities Loaned Fair Value Disclosure
SecuritiesLoanedFairValueDisclosure
35000000 usd
CY2023Q2 jxn Securities Loaned Minimum Fair Value Collateral Percent
SecuritiesLoanedMinimumFairValueCollateralPercent
1.02
CY2023Q2 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
52000000 usd
CY2022Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
36000000 usd
srt Securities Sold Under Agreements To Repurchase Average Rate Paid
SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid
0.0471
srt Securities Sold Under Agreements To Repurchase Average Rate Paid
SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid
0.0019
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
1626000000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
1012000000 usd
jxn Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding
1626000000 usd
jxn Securities Sold Under Agreements To Repurchase Highest Average Amount Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseHighestAverageAmountOutstanding
584000000 usd
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1973000000 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4343000000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-5010000000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4209000000 usd
CY2023Q2 jxn Derivative Assets By Counterparty
DerivativeAssetsByCounterparty
581000000 usd
CY2022Q4 jxn Derivative Assets By Counterparty
DerivativeAssetsByCounterparty
885000000 usd
CY2023Q2 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
519000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
858000000 usd
CY2023Q2 jxn Derivative Liabilities By Counterparty
DerivativeLiabilitiesByCounterparty
1451000000 usd
CY2022Q4 jxn Derivative Liabilities By Counterparty
DerivativeLiabilitiesByCounterparty
1680000000 usd
CY2023Q2 us-gaap Derivative Liability Fair Value Of Collateral
DerivativeLiabilityFairValueOfCollateral
1652000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Of Collateral
DerivativeLiabilityFairValueOfCollateral
1650000000 usd
CY2023Q2 jxn Derivative Downgrade Provision Triggered Disbursement Obligation
DerivativeDowngradeProvisionTriggeredDisbursementObligation
0 usd
CY2022Q4 jxn Derivative Downgrade Provision Triggered Disbursement Obligation
DerivativeDowngradeProvisionTriggeredDisbursementObligation
30000000 usd
CY2023Q2 jxn Derivative Claim
DerivativeClaim
263000000 usd
CY2022Q4 jxn Derivative Claim
DerivativeClaim
27000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
946000000 usd
CY2023Q2 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
946000000 usd
CY2023Q2 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
365000000 usd
CY2023Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
477000000 usd
CY2023Q2 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
20000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
84000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
1816000000 usd
CY2023Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1816000000 usd
CY2023Q2 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
365000000 usd
CY2023Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
1000000 usd
CY2023Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
1439000000 usd
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
11000000 usd
CY2023Q2 us-gaap Securities Loaned Gross
SecuritiesLoanedGross
52000000 usd
CY2023Q2 us-gaap Securities Loaned Asset
SecuritiesLoanedAsset
0 usd
CY2023Q2 us-gaap Securities Loaned
SecuritiesLoaned
52000000 usd
CY2023Q2 us-gaap Securities Loaned Not Offset Policy Election Deduction
SecuritiesLoanedNotOffsetPolicyElectionDeduction
0 usd
CY2023Q2 us-gaap Securities Loaned Collateral Right To Reclaim Cash
SecuritiesLoanedCollateralRightToReclaimCash
52000000 usd
CY2023Q2 us-gaap Securities Loaned Collateral Right To Reclaim Securities
SecuritiesLoanedCollateralRightToReclaimSecurities
0 usd
CY2023Q2 us-gaap Securities Loaned Amount Offset Against Collateral
SecuritiesLoanedAmountOffsetAgainstCollateral
0 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
1626000000 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
1626000000 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
1626000000 usd
CY2023Q2 us-gaap Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral
0 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
3494000000 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned
3494000000 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction
365000000 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
53000000 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
3065000000 usd
CY2023Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral
11000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1270000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1270000000 usd
CY2022Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
385000000 usd
CY2022Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
683000000 usd
CY2022Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
157000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
45000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
2065000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2065000000 usd
CY2022Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
385000000 usd
CY2022Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2022Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
1638000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
42000000 usd
CY2022Q4 us-gaap Securities Loaned Gross
SecuritiesLoanedGross
36000000 usd
CY2022Q4 us-gaap Securities Loaned Asset
SecuritiesLoanedAsset
0 usd
CY2022Q4 us-gaap Securities Loaned
SecuritiesLoaned
36000000 usd
CY2022Q4 us-gaap Securities Loaned Not Offset Policy Election Deduction
SecuritiesLoanedNotOffsetPolicyElectionDeduction
0 usd
CY2022Q4 us-gaap Securities Loaned Collateral Right To Reclaim Cash
SecuritiesLoanedCollateralRightToReclaimCash
36000000 usd
CY2022Q4 us-gaap Securities Loaned Collateral Right To Reclaim Securities
SecuritiesLoanedCollateralRightToReclaimSecurities
0 usd
CY2022Q4 us-gaap Securities Loaned Amount Offset Against Collateral
SecuritiesLoanedAmountOffsetAgainstCollateral
0 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
1012000000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
1012000000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction
SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction
0 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
1012000000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral
0 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
3113000000 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned
3113000000 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction
385000000 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
36000000 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
2650000000 usd
CY2022Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral
42000000 usd
CY2023Q2 jxn Financing Receivable Fair Value Option
FinancingReceivableFairValueOption
509000000 usd
CY2022Q4 jxn Financing Receivable Fair Value Option
FinancingReceivableFairValueOption
582000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
267000000 usd
CY2023Q2 jxn Financing Receivable Fair Value Option
FinancingReceivableFairValueOption
509000000 usd
CY2023Q2 jxn Investments In Limited Partnerships
InvestmentsInLimitedPartnerships
545000000 usd
CY2023Q2 jxn Loans Gross Insurance Policy Fair Value Option
LoansGrossInsurancePolicyFairValueOption
3438000000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
946000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2100000000 usd
CY2023Q2 jxn Gmib Reinsurance Recoverable
GMIBReinsuranceRecoverable
194000000 usd
CY2023Q2 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
5957000000 usd
CY2023Q2 us-gaap Separate Account Assets
SeparateAccountAssets
212719000000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
271049000000 usd
CY2023Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1609000000 usd
CY2023Q2 jxn Funds Withheld Payable Under Reinsurance Treaties
FundsWithheldPayableUnderReinsuranceTreaties
701000000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1816000000 usd
CY2023Q2 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
4463000000 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
10585000000 usd
CY2023Q2 us-gaap Alternative Investment
AlternativeInvestment
2578000000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
393000000 usd
CY2022Q4 jxn Financing Receivable Fair Value Option
FinancingReceivableFairValueOption
582000000 usd
CY2022Q4 jxn Investments In Limited Partnerships
InvestmentsInLimitedPartnerships
440000000 usd
CY2022Q4 jxn Loans Gross Insurance Policy Fair Value Option
LoansGrossInsurancePolicyFairValueOption
3419000000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1270000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4298000000 usd
CY2022Q4 jxn Gmib Reinsurance Recoverable
GMIBReinsuranceRecoverable
221000000 usd
CY2022Q4 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
4865000000 usd
CY2022Q4 us-gaap Separate Account Assets
SeparateAccountAssets
195906000000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
256156000000 usd
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
1135000000 usd
CY2022Q4 jxn Funds Withheld Payable Under Reinsurance Treaties
FundsWithheldPayableUnderReinsuranceTreaties
424000000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2065000000 usd
CY2022Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
5662000000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
11018000000 usd
CY2022Q4 us-gaap Alternative Investment
AlternativeInvestment
2772000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
98000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
69000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
0 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
67000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
-38000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
173000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
4000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
1000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
64000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
106000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
153000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
217000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
35000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
123000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
-152000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
363000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
4000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
31000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
149000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
241000000 usd
CY2023Q2 jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3
-6000000 usd
jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3
31000000 usd
CY2023Q2 jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3
-3000000 usd
jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3
8000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
7000000 usd
CY2022Q2 jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3
1000000 usd
jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3
5000000 usd
CY2022Q2 jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3
28000000 usd
jxn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3
35000000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2023Q2 jxn Federal Home Loan Bank Capital Stock Share Price
FederalHomeLoanBankCapitalStockSharePrice
100
CY2023Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
10303000000 usd
CY2023Q2 jxn Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option
LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption
943000000 usd
CY2023Q2 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
146000000 usd
CY2023Q2 jxn Liability For Future Policy Benefits Annuity Reserves
LiabilityForFuturePolicyBenefitsAnnuityReserves
34277000000 usd
CY2023Q2 us-gaap Liabilities Related To Investment Contracts Fair Value Disclosure
LiabilitiesRelatedToInvestmentContractsFairValueDisclosure
865000000 usd
CY2023Q2 us-gaap Security Owned And Pledged As Collateral Associated Liabilities Fair Value
SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue
5917000000 usd
CY2023Q2 us-gaap Federal Funds Purchased Fair Value Disclosure
FederalFundsPurchasedFairValueDisclosure
2105000000 usd
CY2023Q2 jxn Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option
FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption
20469000000 usd
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2633000000 usd
CY2023Q2 us-gaap Securities Loaned
SecuritiesLoaned
52000000 usd
CY2023Q2 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
1626000000 usd
CY2023Q2 us-gaap Separate Accounts Liability
SeparateAccountsLiability
212719000000 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
10967000000 usd
CY2022Q4 jxn Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option
LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption
958000000 usd
CY2022Q4 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
146000000 usd
CY2022Q4 jxn Liability For Future Policy Benefits Annuity Reserves
LiabilityForFuturePolicyBenefitsAnnuityReserves
36222000000 usd
CY2022Q4 us-gaap Liabilities Related To Investment Contracts Fair Value Disclosure
LiabilitiesRelatedToInvestmentContractsFairValueDisclosure
1128000000 usd
CY2022Q4 us-gaap Security Owned And Pledged As Collateral Associated Liabilities Fair Value
SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue
5887000000 usd
CY2022Q4 us-gaap Federal Funds Purchased Fair Value Disclosure
FederalFundsPurchasedFairValueDisclosure
2004000000 usd
CY2022Q4 jxn Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option
FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption
22533000000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2635000000 usd
CY2022Q4 us-gaap Securities Loaned
SecuritiesLoaned
36000000 usd
CY2022Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
1012000000 usd
CY2022Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
195906000000 usd
us-gaap Deferred Policy Acquisition Costs Text Block1
DeferredPolicyAcquisitionCostsTextBlock1
Deferred Acquisition Costs<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This note contains the new accounting policy for the adoption of LDTI</span></div><div style="padding-right:-18.35pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as DAC in the period they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. DAC are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expected term used to amortize DAC is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, MRBs, and additional liabilities for applicable contracts. For amortization of DAC related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized DAC are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized DAC at the time of the replacement. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the roll-forward of the DAC (in millions, 2022 information recast for the adoption of LDTI). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"></td><td style="width:67.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Variable Annuities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">544 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,209)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Reconciliation of total DAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other product lines, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,599 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,923 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>
CY2023Q2 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
266000000 usd
CY2022Q4 us-gaap Value Of Business Acquired Voba
ValueOfBusinessAcquiredVOBA
224000000 usd
CY2023Q2 us-gaap Deferred Policy Acquisition Costs And Value Of Business Acquired
DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired
12599000000 usd
CY2022Q4 us-gaap Deferred Policy Acquisition Costs And Value Of Business Acquired
DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired
12923000000 usd
CY2023Q2 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
39000000 usd
CY2022Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
15000000 usd
CY2023Q2 us-gaap Reinsurance Receivables Case Basis
ReinsuranceReceivablesCaseBasis
703000000 usd
CY2022Q4 us-gaap Reinsurance Receivables Case Basis
ReinsuranceReceivablesCaseBasis
787000000 usd
CY2023Q2 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
27069000000 usd
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
29046000000 usd
CY2023Q2 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
194000000 usd
CY2022Q4 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
221000000 usd
CY2023Q2 jxn Funds Held Under Reinsurance Agreements Asset Liability Net
FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet
21417000000 usd
CY2022Q4 jxn Funds Held Under Reinsurance Agreements Asset Liability Net
FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet
23226000000 usd
CY2023Q2 us-gaap Funds Held Under Reinsurance Agreements Liability
FundsHeldUnderReinsuranceAgreementsLiability
21170000000 usd
CY2022Q4 us-gaap Funds Held Under Reinsurance Agreements Liability
FundsHeldUnderReinsuranceAgreementsLiability
22957000000 usd
CY2023Q2 jxn Liability For Future Policy Benefit Before Reinsurance Reserve
LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve
9388000000 usd
CY2022Q4 jxn Liability For Future Policy Benefit Before Reinsurance Reserve
LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve
9637000000 usd
CY2023Q2 jxn Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees
LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees
1102000000 usd
CY2022Q4 jxn Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees
LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees
1131000000 usd
CY2023Q2 jxn Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities
LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities
1513000000 usd
CY2022Q4 jxn Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities
LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities
1550000000 usd
CY2023Q2 jxn Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense
PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense
12003000000 usd
CY2022Q4 jxn Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense
PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense
12318000000 usd
us-gaap Liability For Future Policy Benefit Gross Premium Income
LiabilityForFuturePolicyBenefitGrossPremiumIncome
176000000 usd
CY2022 us-gaap Liability For Future Policy Benefit Gross Premium Income
LiabilityForFuturePolicyBenefitGrossPremiumIncome
400000000 usd
us-gaap Liability For Future Policy Benefit Interest Expense
LiabilityForFuturePolicyBenefitInterestExpense
203000000 usd
CY2022 us-gaap Liability For Future Policy Benefit Interest Expense
LiabilityForFuturePolicyBenefitInterestExpense
420000000 usd
CY2023Q2 jxn Funding Agreement
FundingAgreement
2200000000 usd
CY2022Q4 jxn Funding Agreement
FundingAgreement
2100000000 usd
CY2023Q2 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
56477000000 usd
CY2022Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
58190000000 usd
CY2023Q2 us-gaap Separate Account Assets
SeparateAccountAssets
213000000000 usd
CY2022Q4 us-gaap Separate Account Assets
SeparateAccountAssets
196000000000 usd
CY2023Q2 us-gaap Separate Account Assets
SeparateAccountAssets
212719000000 usd
CY2022Q4 us-gaap Separate Account Assets
SeparateAccountAssets
195906000000 usd
CY2023Q2 us-gaap Separate Account Assets
SeparateAccountAssets
212719000000 usd
CY2022Q4 us-gaap Separate Account Assets
SeparateAccountAssets
195906000000 usd
CY2023Q2 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
5957000000 usd
CY2022Q4 us-gaap Market Risk Benefit Asset Amount
MarketRiskBenefitAssetAmount
4865000000 usd
CY2023Q2 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
4463000000 usd
CY2022Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
5662000000 usd
CY2023Q2 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
-1494000000 usd
CY2022Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
797000000 usd
CY2023Q2 us-gaap Market Risk Benefit Increase Decrease From Equity Market Change
MarketRiskBenefitIncreaseDecreaseFromEquityMarketChange
692000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
2633000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2635000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
599000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q2 jxn Long Term Debt Maturity Year Five And Thereafter
LongTermDebtMaturityYearFiveAndThereafter
2034000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
2633000000 usd
CY2022Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
0 usd
CY2023Q2 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
0 usd
CY2023Q2 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
6000000 usd
CY2022Q2 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
0 usd
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
6000000 usd
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
0 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.168
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.528
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.184
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4000000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4000000 usd
CY2023Q2 jxn Asset Based Commission Expense
AssetBasedCommissionExpense
255000000 usd
CY2022Q2 jxn Asset Based Commission Expense
AssetBasedCommissionExpense
250000000 usd
jxn Asset Based Commission Expense
AssetBasedCommissionExpense
505000000 usd
jxn Asset Based Commission Expense
AssetBasedCommissionExpense
525000000 usd
CY2023Q2 jxn Other Commission Expense
OtherCommissionExpense
177000000 usd
CY2022Q2 jxn Other Commission Expense
OtherCommissionExpense
229000000 usd
jxn Other Commission Expense
OtherCommissionExpense
351000000 usd
jxn Other Commission Expense
OtherCommissionExpense
469000000 usd
CY2023Q2 jxn Sub Advisor Expenses
SubAdvisorExpenses
77000000 usd
CY2022Q2 jxn Sub Advisor Expenses
SubAdvisorExpenses
83000000 usd
jxn Sub Advisor Expenses
SubAdvisorExpenses
154000000 usd
jxn Sub Advisor Expenses
SubAdvisorExpenses
173000000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
238000000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
153000000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
474000000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
394000000 usd
CY2023Q2 jxn Deferral Of Acquisition Costs And Sales Inducement Assets
DeferralOfAcquisitionCostsAndSalesInducementAssets
127000000 usd
CY2022Q2 jxn Deferral Of Acquisition Costs And Sales Inducement Assets
DeferralOfAcquisitionCostsAndSalesInducementAssets
172000000 usd
jxn Deferral Of Acquisition Costs And Sales Inducement Assets
DeferralOfAcquisitionCostsAndSalesInducementAssets
248000000 usd
jxn Deferral Of Acquisition Costs And Sales Inducement Assets
DeferralOfAcquisitionCostsAndSalesInducementAssets
352000000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
620000000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
543000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1236000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1209000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-580000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-3290000000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
447000000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-6871000000 usd
CY2023Q2 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax
96000000 usd
CY2022Q2 us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax
591000000 usd
us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax
-50000000 usd
us-gaap Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax
OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax
1356000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
764000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-1017000000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
480000000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-1953000000 usd
CY2023Q2 jxn Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax
OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax
3000000 usd
CY2022Q2 jxn Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax
OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax
17000000 usd
jxn Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax
OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax
-11000000 usd
jxn Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax
OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax
26000000 usd
CY2023Q2 jxn Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax
OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax
181000000 usd
CY2022Q2 jxn Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax
OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax
42000000 usd
jxn Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax
OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax
71000000 usd
jxn Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax
OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax
444000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-1064000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-1623000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-23000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3092000000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-7000000 usd
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-36000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
7000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1057000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1620000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3099000000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
594.44
CY2023Q2 jxn Number Of Classes Of Common Stock
NumberOfClassesOfCommonStock
2 class
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
450000000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82690098 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2337267 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
-3116534 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81910831 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.62
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.62
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.55
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.55
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1217000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3263000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-280000000 usd
us-gaap Net Income Loss
NetIncomeLoss
5457000000 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
13000000 usd
CY2022Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
13000000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1204000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3263000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-293000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5457000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82595287 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85968564 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82620558 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86649493 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2159324 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3200211 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3402618 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84754611 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89168775 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82620558 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90052111 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
14.58
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
37.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
62.98
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
36.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
60.60
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2794562000000 shares
jxn Reclassification Impacts In Cash Flows
ReclassificationImpactsInCashFlows
44000000 usd
us-gaap Fee Income
FeeIncome
3946000000 usd
us-gaap Premiums Earned Net
PremiumsEarnedNet
69000000 usd
us-gaap Net Investment Income
NetInvestmentIncome
1382000000 usd
jxn Gain Loss On Investments And Derivative Instruments Net
GainLossOnInvestmentsAndDerivativeInstrumentsNet
3477000000 usd
us-gaap Revenues
Revenues
8915000000 usd
jxn Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals
DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals
574000000 usd
us-gaap Liability For Future Policy Benefit Remeasurement Gain Loss
LiabilityForFuturePolicyBenefitRemeasurementGainLoss
-29000000 usd
us-gaap Market Risk Benefit Change In Fair Value Gain Loss
MarketRiskBenefitChangeInFairValueGainLoss
723000000 usd
us-gaap Interest Credited To Policyholders Account Balances
InterestCreditedToPolicyholdersAccountBalances
406000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1209000000 usd
jxn Expense Income From Amortization Of Deferred Acquisition Costs
ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts
624000000 usd
us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
2163000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6752000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1233000000 usd
us-gaap Profit Loss
ProfitLoss
5519000000 usd

Files In Submission

Name View Source Status
0001822993-23-000035-index-headers.html Edgar Link pending
0001822993-23-000035-index.html Edgar Link pending
0001822993-23-000035.txt Edgar Link pending
0001822993-23-000035-xbrl.zip Edgar Link pending
exhibit101_2023annualequit.htm Edgar Link pending
exhibit102_2023annualequit.htm Edgar Link pending
exhibit311_q2-2023.htm Edgar Link pending
exhibit312_q2-2023.htm Edgar Link pending
exhibit321_q2-2023.htm Edgar Link pending
exhibit322_q2-2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jxn-20230630.htm Edgar Link pending
jxn-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
jxn-20230630_cal.xml Edgar Link unprocessable
jxn-20230630_lab.xml Edgar Link unprocessable
jxn-20230630_pre.xml Edgar Link unprocessable
jxn-20230630_htm.xml Edgar Link completed
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R130.htm Edgar Link pending
R131.htm Edgar Link pending
R132.htm Edgar Link pending
R133.htm Edgar Link pending
R134.htm Edgar Link pending
R135.htm Edgar Link pending
R136.htm Edgar Link pending
R137.htm Edgar Link pending
R138.htm Edgar Link pending
R139.htm Edgar Link pending
R14.htm Edgar Link pending
R140.htm Edgar Link pending
R141.htm Edgar Link pending
R142.htm Edgar Link pending
R143.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jxn-20230630_def.xml Edgar Link unprocessable